Health Dictionary Find a Doctor

Peritonsillar abscess

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2]

Synonyms and keywords: PTA, Tonsillar abscess, Intratonsillar abscess, Quinsy


Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2]

Overview

Peritonsillar abscess (PTA), also commonly referred to as quinsy, is defined as a collection of pus located between the tonsillar capsule and the pharyngeal constrictor muscles. It is the most common deep tissue infection of the neck.[1] Historically, it has been thought of as a complication of acute tonsillitis. However, recent studies have proposed additional hypothesis surrounding its pathogenesis making the understanding of the disease a medical dilemma.[2]

Historical perspective

In second and third century BC the treatment and pathogenesis of tonsillar pathology was first documented in literature by Celcius. In the 1930s and 1940s prior to the advent of antibiotics, surgical management was the most common treatment option for peritonsillar abscess. Interval tonsillectomy was mostly done after symptom resolution. By 1947, Chaud tonsillectomy or immediate surgical tonsillectomy became the treatment option.[3]

Classification

Peritonsillar abscess may be classified into 3 broad categories based on computed tomographical findings. These are based on the shape of the abscess, location of the abscess and shape and location of the abscess. This may be oval or cap, superior or inferior.[4]

Pathophysiology

The pathogenesis of peritonsillar abscess is still not well-understood.[2] Some authorities have proposed that peritonsillar abscess arises from blockage of drainage from tonsillar crypt following acute tonsillitis results in spread of infection into the peritonsillar space. However, others believe infectious process involving Weber’s gland located in the supratonsillar space account for the abscess formation.[5][3][6][7] Antigenic response following any disturbance arising from within or around the tonsillar crypt mucosa allows for lymphocytic interaction. This disruption in the crypt epithelium may be preceded by infectious process. Invasion and proliferation of the tonsillar crypt by infectious pathogens results in localized edema and influx of neutrophils. This is clinically seen as inflamed tonsil with or without exudation.[5] Pus accumulation within tissue behind the supratonsillar space leads to tonsillar bulging, uvula and palate deviation.

Causes

The cause of peritonsillar abscess is usually polymicrobial. It is predominantly caused by aerobic and anaerobic bacteria.[8] Streptococcus pyogenes is the most common cause of peritonsillar abscess.[9][8][10][11] Other common causes include; Fusobacterium necrophorum, Streptococcus milleri, Staphylococci, Haemophilus, Fusobacterium, Prevotella, Acinetobacter, spp, Candida albicans, Peptostreptococcus spp., Pseudomonas spp., Enterobacter spp. and Klebsiella[9][8]

Differentiating Peritonsillar abscess from other Conditions

Peritonsillar abscess must be differentiated from other upper respiratory diseases and conditions that may cause throat pain and airway obstruction. These include; croup(laryngotracheobronchitis), pharyngitis, tonsilitis, retropharyngeal abscess and epiglottitis.

Epidemiology and Demographics

The incidence of peritonsillar abscess is highest between November to December and April to May in the northern hemisphere. This has been associated with the highest rates of streptococcal pharyngitis and exudative tonsillitis around these times.[12][13] Peritonsillar abscess occurs in all age groups. The highest occurrence is in adults between 20 to 40 years of age.[1][14][15] There is no racial predilection to developing peritonsillar abscess. Males are more commonly affected with peritonsillar abscess than female with male to female ratio of approximately 1.4:1. However, equal male to female ratios have been reported as well.[16][17][18][19][20][21][22]

Screening

There are no screening recommendations for peritonsillar abscess.

Risk Factors

Common risk factors in the development of peritonsillar abscess include smoking, previous peritonsillar abscess episodes, history of recurrent pharyngotonsillitis (Inflammation of the pharynx and tonsils) and poor oral hygiene.[23][24]

Natural History, Complications and Prognosis

Peritonsillar abscess if left untreated may result in extraperitonsillar extension.[25][26] Peritonsillar abscess may be complicated by airway obstruction, aspiration pneumonitis or lung abscess secondary to peritonsillar abscess rupture, hemorrhage from erosion or septic necrosis into carotid sheath, mediastinitis, poststreptococcal sequelae (e.g., glomerulonephritis, rheumatic fever) when infection is caused by Group A streptococcus, and necrotizing fasciitis[1][27][28][29][30] The prognosis of peritonsillar abscess is good with early and appropriate treatment.[31][32][33][34]

Diagnosis

History and Symptoms

Patients presenting with peritonsillar abscess may have a prior history of acute tonsillitis. Symptoms start appearing 2-8 days before the formation of abscess. Common symptoms of peritonsillar abscess include drooling, dysphagia, foul smelling breath, fever, headache, hoarseness, muffled voice (also called hot potato voice), odynophagia, otalgia, sore throat and stridor.[35][1]

Physical Examination

On physical examination, patients are usually acutely ill-looking and may have high temperature, muffled voice (also called “hot potato voice”), contralateral deflection of the uvula, the tonsil is generally displaced inferiorly and medially, facial swelling, tonsillar hypertrophy,, trismus, drooling, tenderness of anterior neck and tender submandibular and anterior cervical lymph node.s[1][36][3][37]

Laboratory Findings

The diagnosis of peritonsillar abscess may be made without the use of laboratory findings however, some nonspecific laboratory findings may be helpful. Complete blood count with differential usually shows leukocytosis with neutrophilic predominance. Serum electrolytes may be useful in patients presenting with dehydration. Gram stain, culture and sensitivity for sample after abscess drainage may yield the causative organism however, emperic therapy should be initiated without delaying for culture results. A routine throat culture for group A streptococcus may be helpful as well.[2][5][3][6][7]

X ray

X ray of the neck is not helpful in the diagnosis of peritonsillar abscess. The initial imaging of choice is ultrasound.[38]

Ultrasound

The diagnosis of peritonsillar abscess may be made without the use of imaging however, imaging options may help in differentiating peritonsillar abscess from other simialr conditions example, peritonsillar cellulitis, retropharyngeal abscess and epiglottitis. On ultrasound, peritonsillar abscess appears as focal irregularly marginated hypoechoic area.[39][40][41][42]

CT

CT scan is helpful in defining the characteristics of the abscess as well as to classify it. It also helps in guiding possible complications. Coronal contrast-enhanced CT scan of the neck may identify the peritonsillar abscess[39] however, the use of CT scan is associated with a clinically significant delay in time to an otolaryngology consultation, time to admission, and time to bedside procedure.[43] CT scan may show diffuse hypodense lesion with rim enhancement in the peritonsillar space.[44]

Treatment

Medical therapy

Parenteral therapy is the preferred first line route of administration until the temperature of the patient has settled and clinically improved and then switched to oral therapy to complete a 14-day course.[32] The preferred emperic therapy is ampicillin-sulbactam with clindamycinas alternative agent. For resistant gram-positive cocci infections intravenous vancomycin or linezolid is added to the above emperic therapy.[45]

Surgical therapy

Incision and drainage, or Tonsillectomy are surgical modalities in the management of peritonsillar abscess. tonsillectomy is oindicated in peritonsillar abscess in severe upper airway obstruction, previous episodes of severe recurrent pharyngitis or peritonsillar abscess and in unresolving peritonsillar abscess after antibiotics and incision and drainage.[46][47][48][49]

Prevention

There are no definite preventive measures for peritonsillar abscess, however, immunization against certain organisms in childhood may decrease the burden of peritonsillar abscess resulting from such infections.

References

  1. 1.0 1.1 1.2 1.3 1.4 Galioto NJ (2008). “Peritonsillar abscess”. Am Fam Physician. 77 (2): 199–202. PMID 18246890.
  2. 2.0 2.1 2.2 Powell EL, Powell J, Samuel JR, Wilson JA (2013). “A review of the pathogenesis of adult peritonsillar abscess: time for a re-evaluation”. J Antimicrob Chemother. 68 (9): 1941–50. doi:10.1093/jac/dkt128. PMID 23612569.
  3. 3.0 3.1 3.2 3.3 Passy V (1994). “Pathogenesis of peritonsillar abscess”. Laryngoscope. 104 (2): 185–90. doi:10.1288/00005537-199402000-00011. PMID 8302122.
  4. Kawabata M, Umakoshi M, Makise T, Miyashita K, Harada M, Nagano H; et al. (2016). “Clinical classification of peritonsillar abscess based on CT and indications for immediate abscess tonsillectomy”. Auris Nasus Larynx. 43 (2): 182–6. doi:10.1016/j.anl.2015.09.014. PMID 26527518.
  5. 5.0 5.1 5.2 L. Michaels, H.B. Hellquist Ear, nose and throat histopathology (2nd ed.)Springer-Verlag, London (2001), pp. 281–286
  6. 6.0 6.1 Blair AB, Booth R, Baugh R (2015). “A unifying theory of tonsillitis, intratonsillar abscess and peritonsillar abscess”. Am J Otolaryngol. 36 (4): 517–20. doi:10.1016/j.amjoto.2015.03.002. PMID 25865201.
  7. 7.0 7.1 Herzon FS, Martin AD (2006). “Medical and surgical treatment of peritonsillar, retropharyngeal, and parapharyngeal abscesses”. Curr Infect Dis Rep. 8 (3): 196–202. PMID 16643771.
  8. 8.0 8.1 8.2 Megalamani SB, Suria G, Manickam U, Balasubramanian D, Jothimahalingam S (2008). “Changing trends in bacteriology of peritonsillar abscess”. J Laryngol Otol. 122 (9): 928–30. doi:10.1017/S0022215107001144. PMID 18039418.
  9. 9.0 9.1 Brook I (2004). “Microbiology and management of peritonsillar, retropharyngeal, and parapharyngeal abscesses”. J Oral Maxillofac Surg. 62 (12): 1545–50. PMID 15573356.
  10. Snow DG, Campbell JB, Morgan DW (1991). “The microbiology of peritonsillar sepsis”. J Laryngol Otol. 105 (7): 553–5. PMID 1875138.
  11. Matsuda A, Tanaka H, Kanaya T, Kamata K, Hasegawa M (2002). “Peritonsillar abscess: a study of 724 cases in Japan”. Ear Nose Throat J. 81 (6): 384–9. PMID 12092281.
  12. Belleza WG, Kalman S (2006). “Otolaryngologic emergencies in the outpatient setting”. Med Clin North Am. 90 (2): 329–53. doi:10.1016/j.mcna.2005.12.001. PMID 16448878.
  13. Bisno AL, Gerber MA, Gwaltney JM, Kaplan EL, Schwartz RH, Infectious Diseases Society of America (2002). “Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America”. Clin Infect Dis. 35 (2): 113–25. doi:10.1086/340949. PMID 12087516.
  14. Steyer TE (2002). “Peritonsillar abscess: diagnosis and treatment”. Am Fam Physician. 65 (1): 93–6. PMID 11804446.
  15. Khayr W, Taepke J (2005). “Management of peritonsillar abscess: needle aspiration versus incision and drainage versus tonsillectomy”. Am J Ther. 12 (4): 344–50. PMID 16041198.
  16. Ong YK, Goh YH, Lee YL (2004). “Peritonsillar infections: local experience”. Singapore Med J. 45 (3): 105–9. PMID 15029410.
  17. Marom T, Cinamon U, Itskoviz D, Roth Y (2010). “Changing trends of peritonsillar abscess”. Am J Otolaryngol. 31 (3): 162–7. doi:10.1016/j.amjoto.2008.12.003. PMID 20015734.
  18. Klug TE (2014). “Incidence and microbiology of peritonsillar abscess: the influence of season, age, and gender”. Eur J Clin Microbiol Infect Dis. 33 (7): 1163–7. doi:10.1007/s10096-014-2052-8. PMID 24474247.
  19. Gavriel H, Lazarovitch T, Pomortsev A, Eviatar E (2009). “Variations in the microbiology of peritonsillar abscess”. Eur J Clin Microbiol Infect Dis. 28 (1): 27–31. doi:10.1007/s10096-008-0583-6. PMID 18612664.
  20. Sunnergren O, Swanberg J, Mölstad S (2008). “Incidence, microbiology and clinical history of peritonsillar abscesses”. Scand J Infect Dis. 40 (9): 752–5. doi:10.1080/00365540802040562. PMID 19086341.
  21. Hidaka H, Kuriyama S, Yano H, Tsuji I, Kobayashi T (2011). “Precipitating factors in the pathogenesis of peritonsillar abscess and bacteriological significance of the Streptococcus milleri group”. Eur J Clin Microbiol Infect Dis. 30 (4): 527–32. doi:10.1007/s10096-010-1114-9. PMID 21086007.
  22. Costales-Marcos M, López-Álvarez F, Núñez-Batalla F, Moreno-Galindo C, Alvarez Marcos C, Llorente-Pendás JL (2012). “[Peritonsillar infections: prospective study of 100 consecutive cases]”. Acta Otorrinolaringol Esp. 63 (3): 212–7. doi:10.1016/j.otorri.2012.01.001. PMID 22425204.
  23. Lehnerdt G, Senska K, Fischer M, Jahnke K (2005). “[Smoking promotes the formation of peritonsillar abscesses]”. Laryngorhinootologie. 84 (9): 676–9. doi:10.1055/s-2005-870289. PMID 16142623.
  24. Dilkes MG, Dilkes JE, Ghufoor K (1992). “Smoking and quinsy”. Lancet. 339 (8808): 1552. PMID 1351238.
  25. Coughlin AM, Baugh RF, Pine HS (2014). “Lingual tonsil abscess with parapharyngeal extension: a case report”. Ear Nose Throat J. 93 (9): E7–8. PMID 25255362.
  26. Deeva YV (2015). “[SURGICAL TREATMENT OF TONSILLAR NECK PHLEGMON]”. Klin Khir (7): 47–8. PMID 26591220.
  27. Goldenberg D, Golz A, Joachims HZ (1997). “Retropharyngeal abscess: a clinical review”. J Laryngol Otol. 111 (6): 546–50. PMID 9231089.
  28. Stevens HE (1990). “Vascular complication of neck space infection: case report and literature review”. J Otolaryngol. 19 (3): 206–10. PMID 2355414.
  29. Greinwald JH, Wilson JF, Haggerty PG (1995). “Peritonsillar abscess: an unlikely cause of necrotizing fasciitis”. Ann Otol Rhinol Laryngol. 104 (2): 133–7. doi:10.1177/000348949510400209. PMID 7857015.
  30. Wenig BL, Shikowitz MJ, Abramson AL (1984). “Necrotizing fasciitis as a lethal complication of peritonsillar abscess”. Laryngoscope. 94 (12 Pt 1): 1576–9. PMID 6594557.
  31. Powell J, Wilson JA (2012). “An evidence-based review of peritonsillar abscess”. Clin Otolaryngol. 37 (2): 136–45. doi:10.1111/j.1749-4486.2012.02452.x. PMID 22321140.
  32. 32.0 32.1 Apostolopoulos NJ, Nikolopoulos TP, Bairamis TN (1995). “Peritonsillar abscess in children. Is incision and drainage an effective management?”. Int J Pediatr Otorhinolaryngol. 31 (2–3): 129–35. PMID 7782170.
  33. Johnson RF, Stewart MG, Wright CC (2003). “An evidence-based review of the treatment of peritonsillar abscess”. Otolaryngol Head Neck Surg. 128 (3): 332–43. doi:10.1067/mhn.2003.93. PMID 12646835.
  34. Herzon FS (1995). “Harris P. Mosher Award thesis. Peritonsillar abscess: incidence, current management practices, and a proposal for treatment guidelines”. Laryngoscope. 105 (8 Pt 3 Suppl 74): 1–17. PMID 7630308.
  35. Ferri, Fred (2015). Ferri’s clinical advisor 2015 : 5 books in 1. Philadelphia, PA: Elsevier/Mosby. ISBN 978-0323083751.
  36. Ferri, Fred (2015). Ferri’s clinical advisor 2015 : 5 books in 1. Philadelphia, PA: Elsevier/Mosby. ISBN 978-0323083751.
  37. Nwe TT, Singh B (2000). “Management of pain in peritonsillar abscess”. J Laryngol Otol. 114 (10): 765–7. PMID 11127146.
  38. Secko M, Sivitz A (2015). “Think ultrasound first for peritonsillar swelling”. Am J Emerg Med. 33 (4): 569–72. doi:10.1016/j.ajem.2015.01.031. PMID 25737413.
  39. 39.0 39.1 Bandarkar AN, Adeyiga AO, Fordham MT, Preciado D, Reilly BK (2016). “Tonsil ultrasound: technical approach and spectrum of pediatric peritonsillar infections”. Pediatr Radiol. 46 (7): 1059–67. doi:10.1007/s00247-015-3505-7. PMID 26637999.
  40. Scott PM, Loftus WK, Kew J, Ahuja A, Yue V, van Hasselt CA (1999). “Diagnosis of peritonsillar infections: a prospective study of ultrasound, computerized tomography and clinical diagnosis”. J Laryngol Otol. 113 (3): 229–32. PMID 10435129.
  41. Lyon M, Blaivas M (2005). “Intraoral ultrasound in the diagnosis and treatment of suspected peritonsillar abscess in the emergency department”. Acad Emerg Med. 12 (1): 85–8. doi:10.1197/j.aem.2004.08.045. PMID 15635144.
  42. Boesen T, Jensen F (1992). “Preoperative ultrasonographic verification of peritonsillar abscesses in patients with severe tonsillitis”. Eur Arch Otorhinolaryngol. 249 (3): 131–3. PMID 1642863.
  43. Grant MC, Guarisco JL (2016). “Association Between Computed Tomographic Scan and Timing and Treatment of Peritonsillar Abscess in Children”. JAMA Otolaryngol Head Neck Surg. 142 (11): 1051–1055. doi:10.1001/jamaoto.2016.2035. PMID 27533126.
  44. Chen Y, Yang Q, Wang T, Li J, Ye J, Liu X; et al. (2014). “[Application of enhanced CT in the differential diagnosis of peritonsillar abscess and intratonsillar abscess]”. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 49 (2): 131–5. PMID 24742512.
  45. Principles and Practice of Pediatric Infectious Diseases, 4th ed, Long SS, Pickering LK, Prober CG (Eds), Elsevier Saunders, New York 2012. p.205.
  46. Windfuhr JP (2016). “Indications for tonsillectomy stratified by the level of evidence”. GMS Curr Top Otorhinolaryngol Head Neck Surg. 15: Doc09. doi:10.3205/cto000136. PMC 5169082. PMID 28025609.
  47. Mcleod R, Brahmabhatt P, Owens D (2016). “Tonsillectomy is not a procedure of limited value – the unseen costs of tonsillitis and quinsy on hospital bed consumption”. Clin Otolaryngol. doi:10.1111/coa.12773. PMID 27754588.
  48. Windfuhr JP (2016). “[Evidence-based Indications for Tonsillectomy]”. Laryngorhinootologie. 95 Suppl 1: S38–87. doi:10.1055/s-0041-109590. PMID 27128404.
  49. Rasp G (2015). “[Tonsillectomy]”. Laryngorhinootologie. 94 (4): 218–9. doi:10.1055/s-0035-1548998. PMID 25837365.

Template:WH Template:WS

Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2]

Overview

In second and third century BC, the treatment and pathogenesis of tonsillar pathology was first documented in literature by Celcius. In the 1930s and 1940s prior to the advent of antibiotics, surgical management was the most common treatment option for peritonsillar abscess. Interval tonsillectomy was mostly done after symptom resolution. By 1947, Chaud tonsillectomy or immediate surgical tonsillectomy became the treatment option.[1]

Historical perspective

The outline below shows the historical perspective of peritonsillar abscess.[1]

  • In second and third century BC, Celcius was the first to document in literature the treatment and pathogenesis of tonsillar pathology.
  • In 1700s peritonsillar abscess was first described by Marcus.
  • In the 1930s and 1940s prior to the advent of antibiotics, surgical management was the most common treatment option for peritonsillar abscess. Interval tonsillectomy was mostly done after symptom resolution.
  • By 1947, Chaud tonsillectomy or immediate surgical tonsillectomy became the treatment option.

References

  1. 1.0 1.1 Passy V (1994). “Pathogenesis of peritonsillar abscess”. Laryngoscope. 104 (2): 185–90. doi:10.1288/00005537-199402000-00011. PMID 8302122.

Template:WH Template:WS

Peritonsillar abscess classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2]

Overview

Peritonsillar abscess may be classified into 3 broad categories based on computed tomographical findings. These are based on the shape of the abscess, location of the abscess and shape and location of the abscess. This may be oval or cap, superior or inferior.[1]

Classification

On the basis of computed tomographical findings, peritonsillar abscess may be classified into 3 broad categories based on the following:

1. Shape of the abscess

On the basis of shape it may be classified as:[1]

  • Oval type or
  • Cap type

2. Location of the abscess

On the basis of abscess location it may be differentiated into the following:[1]

3. Shape and location of the abscess

On the basis of shape and location it may be classified as:[1]

  • This is the most common type
  • Inferior cap-type abscess are at highest incidence of extraperitonsillar spread than the other categories of peritonsillar abscess.

References

  1. 1.0 1.1 1.2 1.3 Kawabata M, Umakoshi M, Makise T, Miyashita K, Harada M, Nagano H; et al. (2016). “Clinical classification of peritonsillar abscess based on CT and indications for immediate abscess tonsillectomy”. Auris Nasus Larynx. 43 (2): 182–6. doi:10.1016/j.anl.2015.09.014. PMID 26527518.

Template:WH Template:WS

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2]

Overview

The pathogenesis of peritonsillar abscess is still not well-understood.[1] Some authorities have proposed that peritonsillar abscess arises from blockage of drainage from tonsillar crypt following acute tonsillitis resulting in spread of infection into the peritonsillar space. However, others believe infectious process involving Weber’s gland located in the supratonsillar space account for the abscess formation.[2][3][4][5] Antigenic response following any disturbance arising from within or around the tonsillar crypt mucosa allows for lymphocytic interaction. This disruption in the crypt epithelium may be preceded by infectious process. Invasion and proliferation of the tonsillar crypt by infectious pathogens results in localized edema and influx of neutrophils. This is clinically seen as inflamed tonsil with or without exudation.[2] Pus accumulation within tissue behind the supratonsillar space leads to tonsillar bulging, uvula and palate deviation.

Pathophysiology

Anatomy

A good understanding of the tonsil and its surrounding space is important in the pathogenesis of peritonsillar abscess. The palatine tonsils are found in an anatomical structure called tonsillar fossa. This fossa is bounded anteriorly by palatoglossal muscle, posteriorly by palatopharyngeal muscle, laterally by a fibrous capsule and tonsillar crypts medially. Contents of the tonsillar crypts are expelled by contraction of the tonsillopharyngeus muscle.[2] The tonsils form during the last months of pregnancy and becomes fully formed by 6 to 7 years of age. It then undergoes involution until small size remains in older population. Located within the soft palate is the supratonsillar space occupied by series of 20 to 25 salivary glands described as Weber’s glands. The ducts of these glands form a common duct which opens onto the posterior surface of the tonsil after passing through the tonsillar capsule. It is proposed that the secretions from these glands play a rule in food digestion. Peritonsillar abscesses form in the area between the palatine tonsil and its capsule.

Pathogenesis

The pathogenesis of peritonsillar abscess is still not well-understood.[1] There are two proposed theories believed to be involved in the pathogenesis of peritonsillar abscess formation.[2][3][4][5]

  • Some authorities believe that blockage of drainage from tonsillar crypt in acute tonsillitis results in spread of infection into the peritonsillar space.
  • 2. Involvement of Weber’s gland account for the abscess formation.
  • Some believe that peritonsillar abscess arises from infectious process involving group of salivary glands called Weber’s glands located in the supratonsillar space.

Antigenic response following any disturbance arising from within the tonsillar crypt mucosa allows for lymphocytic interaction. This disruption in the crypt epithelium may be preceded by infectious process. Invasion and proliferation of the tonsillar crypt by infectious pathogens results in localized edema and influx of neutrophils. This is clinically seen as inflamed tonsil with or without exudation.[2] Pus accumulation within tissue behind the supratonsillar space leads to tonsillar bulging, uvula and palate deviation.

Microscopic pathology

Microscopic pathology shows cellular swelling and invasion of inflammatory cells predominately neutrophils.

References

  1. 1.0 1.1 Powell EL, Powell J, Samuel JR, Wilson JA (2013). “A review of the pathogenesis of adult peritonsillar abscess: time for a re-evaluation”. J Antimicrob Chemother. 68 (9): 1941–50. doi:10.1093/jac/dkt128. PMID 23612569.
  2. 2.0 2.1 2.2 2.3 2.4 L. Michaels, H.B. Hellquist Ear, nose and throat histopathology (2nd ed.)Springer-Verlag, London (2001), pp. 281–286
  3. 3.0 3.1 Passy V (1994). “Pathogenesis of peritonsillar abscess”. Laryngoscope. 104 (2): 185–90. doi:10.1288/00005537-199402000-00011. PMID 8302122.
  4. 4.0 4.1 Blair AB, Booth R, Baugh R (2015). “A unifying theory of tonsillitis, intratonsillar abscess and peritonsillar abscess”. Am J Otolaryngol. 36 (4): 517–20. doi:10.1016/j.amjoto.2015.03.002. PMID 25865201.
  5. 5.0 5.1 Herzon FS, Martin AD (2006). “Medical and surgical treatment of peritonsillar, retropharyngeal, and parapharyngeal abscesses”. Curr Infect Dis Rep. 8 (3): 196–202. PMID 16643771.

Template:WH Template:WS

Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2]

Overview

The cause of peritonsillar abscess is usually polymicrobial. It is predominantly caused by aerobic and anaerobic bacteria.[1] Streptococcus pyogenes is the most common cause of peritonsillar abscess.[2][1][3][4] Other common causes include; Fusobacterium necrophorum, Streptococcus milleri, Staphylococci, Haemophilus, Prevotella, Acinetobacter spp., Candida albicans, Peptostreptococcus spp., Pseudomonas spp., Enterobacter spp. and Klebsiella.[2][1]

Causes

The cause of peritonsillar abscess is usually polymicrobial. It is predominantly caused by aerobic and anaerobic bacteria.[1]

Life-threatening causes

There as no life-threatening causes of peritonsillar abscess.[2][1]

Most common cause

The most frequent pathogen of peritonsillar abscess is Streptococcus pyogenes.[2][1][3][4]

Common causes

Some common causes of peritonsillar abscess include:[2][1]

Less common causes

Less common causes of peritonsillar abscess include:[2][1]

Causes by Organ System

Cardiovascular No underlying causes
Chemical/Poisoning No underlying causes
Dental No underlying causes
Dermatologic No underlying causes
Drug Side Effect No underlying causes
Ear Nose Throat No underlying causes
Endocrine No underlying causes
Environmental No underlying causes
Gastroenterologic No underlying causes
Genetic No underlying causes
Hematologic No underlying causes
Iatrogenic No underlying causes
Infectious Disease Acinetobacter, Candida albicans, Enterobacter, Fusobacterium necrophorum, Haemophilus, Klebsiella, Peptostreptococcus, Porphyromonas, Prevotella, Pseudomonas, Staphylococcus aureus (including methicillin-resistant Staphilococcus aureus), Streptococcus anginosus, Streptococcus milleri, Streptococcus pyogenes (group A streptococcus), Veillonella species


Musculoskeletal/Orthopedic No underlying causes
Neurologic No underlying causes
Nutritional/Metabolic No underlying causes
Obstetric/Gynecologic No underlying causes
Oncologic No underlying causes
Ophthalmologic No underlying causes
Overdose/Toxicity No underlying causes
Psychiatric No underlying causes
Pulmonary No underlying causes
Renal/Electrolyte No underlying causes
Rheumatology/Immunology/Allergy No underlying causes
Sexual No underlying causes
Trauma No underlying causes
Urologic No underlying causes
Miscellaneous No underlying causes

Causes in Alphabetical Order

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 Megalamani SB, Suria G, Manickam U, Balasubramanian D, Jothimahalingam S (2008). “Changing trends in bacteriology of peritonsillar abscess”. J Laryngol Otol. 122 (9): 928–30. doi:10.1017/S0022215107001144. PMID 18039418.
  2. 2.0 2.1 2.2 2.3 2.4 2.5 Brook I (2004). “Microbiology and management of peritonsillar, retropharyngeal, and parapharyngeal abscesses”. J Oral Maxillofac Surg. 62 (12): 1545–50. PMID 15573356.
  3. 3.0 3.1 Snow DG, Campbell JB, Morgan DW (1991). “The microbiology of peritonsillar sepsis”. J Laryngol Otol. 105 (7): 553–5. PMID 1875138.
  4. 4.0 4.1 Matsuda A, Tanaka H, Kanaya T, Kamata K, Hasegawa M (2002). “Peritonsillar abscess: a study of 724 cases in Japan”. Ear Nose Throat J. 81 (6): 384–9. PMID 12092281.

Template:WH Template:WS

Differentiating Peritonsillar abscess from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2]

Overview

Peritonsillar abscess must be differentiated from other upper respiratory diseases and conditions that may cause throat pain and airway obstruction. These include; croup(laryngotracheobronchitis), pharyngitis, tonsilitis, retropharyngeal abscess and epiglottitis.

Differential diagnosis

Peritonsillar abscess must be differentiated from other upper respiratory diseases and conditions that may cause throat pain and airway obstruction as shown in the table below:

Disease/Variable Presentation Causes Physical exams findings Age commonly affected Imaging finding Treatment
Peritonsillar abscess Severe sore throat, otalgia fever, a “hot potato” or muffled voice, drooling, and trismus[1] Aerobic and anaerobic

bacteria most common is

Streptococcus

pyogenes.[2][3][4][5]

Contralateral deflection of the uvula,

the tonsil is displaced inferiorly and medially, tender submandibular and anterior cervical lymph nodes, tonsillar hypertrophy with likely peritonsillar edema.

The highest occurrence is in adults between 20 to 40 years of age.[1] On ultrasound peritonsillar abscess appears as focal irregularly marginated hypoechoic area.[6][7][8][9][6][7] Ampicillin-sulbactam, Clindamycin, Vancomycin or Linezolid
Croup Has cough and stridor but no drooling. Others are Hoarseness, Difficulty breathing, symptoms of the common cold, Runny nose, Fever Parainfluenza virus Suprasternal and intercostal indrawing,[10] Inspiratory stridor, expiratory wheezing, Sternal wall retractions[11] Mainly 6 months and 3 years old

rarely, adolescents and adults[12]

Steeple sign on neck X-ray Dexamethasone and nebulised epinephrine
Epiglottitis Stridor and drooling but no cough. Other symptoms include difficulty breathing, fever, chills, difficulty swallowing, hoarseness of voice H. influenza type b,

beta-hemolytic streptococci, Staphylococcus aureus,

fungi and viruses.

Cyanosis, Cervical lymphadenopathy, Inflamed epiglottis Used to be mostly found in

pediatric age group between 3 to 5 years,

however, recent trend favors adults

as most commonly affected individuals

with a mean age of 44.94 years

Thumbprint sign on neck x-ray Airway maintenance, parenteral Cefotaxime or Ceftriaxone in combination with Vancomycin. Adjuvant therapy includes corticosteroids and racemic Epinephrine.[13][14]
Pharyngitis Sore throat, pain on swallowing, fever, headache, abdominal pain, nausea and vomiting Group A beta-hemolytic

streptococcus.

Inflamed pharynx with or without exudate Mostly in children and young adults,

with 50% of cases identified

between the ages of 5 to 24 years

_ Antimicrobial therapy mainly penicillin-based and analgesics.
Tonsilitis Sore throat, pain on swallowing, fever, headache, and cough Most common cause is

viral including adenovirus,

rhinovirus, influenza,

coronavirus, and

respiratory syncytial virus.

Second most common

causes are bacterial;

Group A streptococcal

bacteria[15]

Fever, especially 100°F or higher. Erythema, edema and exudate of the tonsils,[16] cervical lymphadenopathy, and Dysphonia.Invalid parameter “ref” in <ref> tag. The supported parameters are: dir, follow, group, name.[17][18] Primarily affects children

between 5 and 15 years old.

Intraoral or transcutaneous USG may show an abscess making CT scan unnecessary.[19][17][18] Antimicrobial therapy mainly penicillin-based and analgesics with tonsilectomy in selected cases.
Retropharyngeal abscess Neck pain, stiff neck, torticollis, fever, malaise, stridor, and barking cough Polymicrobial infection.

Mostly; Streptococcus

pyogenes, Staphylococcus aureus and respiratory anaerobes (example; Fusobacteria, Prevotella,

and Veillonella species)[20][21][22][2][23][24]

Child may be unable to open the mouth widely. May have enlarged cervical lymph nodes and neck mass. Mostly between 2-4 years, but can occur in other age groups.[25][26] On CT scan, a mass impinging on the posterior pharyngeal wall with rim enhancement is seen[27][28] Immediate surgical drainage and antimicrobial therapy. emperic therapy involves; ampicillinsulbactam or clindamycin.

References

  1. 1.0 1.1 Galioto NJ (2008). “Peritonsillar abscess”. Am Fam Physician. 77 (2): 199–202. PMID 18246890.
  2. 2.0 2.1 Brook I (2004). “Microbiology and management of peritonsillar, retropharyngeal, and parapharyngeal abscesses”. J Oral Maxillofac Surg. 62 (12): 1545–50. PMID 15573356.
  3. Megalamani SB, Suria G, Manickam U, Balasubramanian D, Jothimahalingam S (2008). “Changing trends in bacteriology of peritonsillar abscess”. J Laryngol Otol. 122 (9): 928–30. doi:10.1017/S0022215107001144. PMID 18039418.
  4. Snow DG, Campbell JB, Morgan DW (1991). “The microbiology of peritonsillar sepsis”. J Laryngol Otol. 105 (7): 553–5. PMID 1875138.
  5. Matsuda A, Tanaka H, Kanaya T, Kamata K, Hasegawa M (2002). “Peritonsillar abscess: a study of 724 cases in Japan”. Ear Nose Throat J. 81 (6): 384–9. PMID 12092281.
  6. 6.0 6.1 Lyon M, Blaivas M (2005). “Intraoral ultrasound in the diagnosis and treatment of suspected peritonsillar abscess in the emergency department”. Acad Emerg Med. 12 (1): 85–8. doi:10.1197/j.aem.2004.08.045. PMID 15635144.
  7. 7.0 7.1 Boesen T, Jensen F (1992). “Preoperative ultrasonographic verification of peritonsillar abscesses in patients with severe tonsillitis”. Eur Arch Otorhinolaryngol. 249 (3): 131–3. PMID 1642863.
  8. Bandarkar AN, Adeyiga AO, Fordham MT, Preciado D, Reilly BK (2016). “Tonsil ultrasound: technical approach and spectrum of pediatric peritonsillar infections”. Pediatr Radiol. 46 (7): 1059–67. doi:10.1007/s00247-015-3505-7. PMID 26637999.
  9. Scott PM, Loftus WK, Kew J, Ahuja A, Yue V, van Hasselt CA (1999). “Diagnosis of peritonsillar infections: a prospective study of ultrasound, computerized tomography and clinical diagnosis”. J Laryngol Otol. 113 (3): 229–32. PMID 10435129.
  10. Johnson D (2009). “Croup”. BMJ Clin Evid. 2009. PMC 2907784. PMID 19445760.
  11. Giordano S, Adamo P, Monaci F, Pittao E, Tretiach M, Bargagli R (2009). “Bags with oven-dried moss for the active monitoring of airborne trace elements in urban areas”. Environ Pollut. 157 (10): 2798–805. doi:10.1016/j.envpol.2009.04.020. PMID 19457602.
  12. Tong MC, Chu MC, Leighton SE, van Hasselt CA (1996). “Adult croup”. Chest. 109 (6): 1659–62. PMID 8769531.
  13. Nickas BJ (2005). “A 60-year-old man with stridor, drooling, and “tripoding” following a nasal polypectomy”. J Emerg Nurs. 31 (3): 234–5, quiz 321. doi:10.1016/j.jen.2004.10.015. PMID 15983574.
  14. Wick F, Ballmer PE, Haller A (2002). “Acute epiglottis in adults”. Swiss Med Wkly. 132 (37–38): 541–7. PMID 12557859.
  15. Putto A (1987). “Febrile exudative tonsillitis: viral or streptococcal?”. Pediatrics. 80 (1): 6–12. PMID 3601520.
  16. Stelter K (2014). “Tonsillitis and sore throat in children”. GMS Curr Top Otorhinolaryngol Head Neck Surg. 13: Doc07. doi:10.3205/cto000110. PMC 4273168. PMID 25587367.
  17. 17.0 17.1 Nogan S, Jandali D, Cipolla M, DeSilva B (2015). “The use of ultrasound imaging in evaluation of peritonsillar infections”. Laryngoscope. 125 (11): 2604–7. doi:10.1002/lary.25313. PMID 25946659.
  18. 18.0 18.1 Fordham MT, Rock AN, Bandarkar A, Preciado D, Levy M, Cohen J; et al. (2015). “Transcervical ultrasonography in the diagnosis of pediatric peritonsillar abscess”. Laryngoscope. 125 (12): 2799–804. doi:10.1002/lary.25354. PMID 25945805.
  19. Kawabata M, Umakoshi M, Makise T, Miyashita K, Harada M, Nagano H; et al. (2016). “Clinical classification of peritonsillar abscess based on CT and indications for immediate abscess tonsillectomy”. Auris Nasus Larynx. 43 (2): 182–6. doi:10.1016/j.anl.2015.09.014. PMID 26527518.
  20. Cheng J, Elden L (2013). “Children with deep space neck infections: our experience with 178 children”. Otolaryngol Head Neck Surg. 148 (6): 1037–42. doi:10.1177/0194599813482292. PMID 23520072.
  21. Abdel-Haq N, Quezada M, Asmar BI (2012). “Retropharyngeal abscess in children: the rising incidence of methicillin-resistant Staphylococcus aureus”. Pediatr Infect Dis J. 31 (7): 696–9. doi:10.1097/INF.0b013e318256fff0. PMID 22481424.
  22. Inman JC, Rowe M, Ghostine M, Fleck T (2008). “Pediatric neck abscesses: changing organisms and empiric therapies”. Laryngoscope. 118 (12): 2111–4. doi:10.1097/MLG.0b013e318182a4fb. PMID 18948832.
  23. Wright CT, Stocks RM, Armstrong DL, Arnold SR, Gould HJ (2008). “Pediatric mediastinitis as a complication of methicillin-resistant Staphylococcus aureus retropharyngeal abscess”. Arch Otolaryngol Head Neck Surg. 134 (4): 408–13. doi:10.1001/archotol.134.4.408. PMID 18427007.
  24. Asmar BI (1990). “Bacteriology of retropharyngeal abscess in children”. Pediatr Infect Dis J. 9 (8): 595–7. PMID 2235179.
  25. Craig FW, Schunk JE (2003). “Retropharyngeal abscess in children: clinical presentation, utility of imaging, and current management”. Pediatrics. 111 (6 Pt 1): 1394–8. PMID 12777558.
  26. Coulthard M, Isaacs D (1991). “Neonatal retropharyngeal abscess”. Pediatr Infect Dis J. 10 (7): 547–9. PMID 1876473.
  27. Philpott CM, Selvadurai D, Banerjee AR (2004). “Paediatric retropharyngeal abscess”. J Laryngol Otol. 118 (12): 919–26. PMID 15667676.
  28. Vural C, Gungor A, Comerci S (2003). “Accuracy of computerized tomography in deep neck infections in the pediatric population”. Am J Otolaryngol. 24 (3): 143–8. PMID 12761699.

Template:WH Template:WS

Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2]

Overview

The incidence of peritonsillar abscess is highest between November to December and April to May in the northern hemisphere. This has been associated with the highest rates of streptococcal pharyngitis and exudative tonsillitis around these times.[1][2] Peritonsillar abscess occurs in all age groups. The highest occurrence is in adults between 20 to 40 years of age.[3][4][5] There is no racial predilection to developing peritonsillar abscess. Males are more commonly affected with peritonsillar abscess than female with male to female ratio of approximately 1.4:1. However, equal male to female ratios have been reported as well.[6][7][8][9][10][11][12]

Epidemiology and demographics

Prevalence and incidence

The incidence of peritonsillar abscess is highest between November to December and April to May in the northern hemisphere. This has been associated with the highest rates of streptococcal pharyngitis and exudative tonsillitis around these times.[1][2]

Age

Peritonsillar abscess occur in all age groups. The highest occurrence is in adults between 20 to 40 years of age.[3][4][5]

Race

There is no racial predilection to developing peritonsillar abscess.

Gender

Males are more commonly affected with peritonsillar abscess than female with male to female ratio of approximately 1.4:1. However, equal male to female ratios have been reported in some studies as well.[6][7][8][9][10][11][12]

Developed and developing countries

Peritonsillar abscess has not been found to vary significantly among countries.

References

  1. 1.0 1.1 Belleza WG, Kalman S (2006). “Otolaryngologic emergencies in the outpatient setting”. Med Clin North Am. 90 (2): 329–53. doi:10.1016/j.mcna.2005.12.001. PMID 16448878.
  2. 2.0 2.1 Bisno AL, Gerber MA, Gwaltney JM, Kaplan EL, Schwartz RH, Infectious Diseases Society of America (2002). “Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America”. Clin Infect Dis. 35 (2): 113–25. doi:10.1086/340949. PMID 12087516.
  3. 3.0 3.1 Galioto NJ (2008). “Peritonsillar abscess”. Am Fam Physician. 77 (2): 199–202. PMID 18246890.
  4. 4.0 4.1 Steyer TE (2002). “Peritonsillar abscess: diagnosis and treatment”. Am Fam Physician. 65 (1): 93–6. PMID 11804446.
  5. 5.0 5.1 Khayr W, Taepke J (2005). “Management of peritonsillar abscess: needle aspiration versus incision and drainage versus tonsillectomy”. Am J Ther. 12 (4): 344–50. PMID 16041198.
  6. 6.0 6.1 Ong YK, Goh YH, Lee YL (2004). “Peritonsillar infections: local experience”. Singapore Med J. 45 (3): 105–9. PMID 15029410.
  7. 7.0 7.1 Marom T, Cinamon U, Itskoviz D, Roth Y (2010). “Changing trends of peritonsillar abscess”. Am J Otolaryngol. 31 (3): 162–7. doi:10.1016/j.amjoto.2008.12.003. PMID 20015734.
  8. 8.0 8.1 Klug TE (2014). “Incidence and microbiology of peritonsillar abscess: the influence of season, age, and gender”. Eur J Clin Microbiol Infect Dis. 33 (7): 1163–7. doi:10.1007/s10096-014-2052-8. PMID 24474247.
  9. 9.0 9.1 Gavriel H, Lazarovitch T, Pomortsev A, Eviatar E (2009). “Variations in the microbiology of peritonsillar abscess”. Eur J Clin Microbiol Infect Dis. 28 (1): 27–31. doi:10.1007/s10096-008-0583-6. PMID 18612664.
  10. 10.0 10.1 Sunnergren O, Swanberg J, Mölstad S (2008). “Incidence, microbiology and clinical history of peritonsillar abscesses”. Scand J Infect Dis. 40 (9): 752–5. doi:10.1080/00365540802040562. PMID 19086341.
  11. 11.0 11.1 Hidaka H, Kuriyama S, Yano H, Tsuji I, Kobayashi T (2011). “Precipitating factors in the pathogenesis of peritonsillar abscess and bacteriological significance of the Streptococcus milleri group”. Eur J Clin Microbiol Infect Dis. 30 (4): 527–32. doi:10.1007/s10096-010-1114-9. PMID 21086007.
  12. 12.0 12.1 Costales-Marcos M, López-Álvarez F, Núñez-Batalla F, Moreno-Galindo C, Alvarez Marcos C, Llorente-Pendás JL (2012). “[Peritonsillar infections: prospective study of 100 consecutive cases]”. Acta Otorrinolaringol Esp. 63 (3): 212–7. doi:10.1016/j.otorri.2012.01.001. PMID 22425204.

Template:WH Template:WS

Screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2]

Overview

There are no screening recommendations for peritonsillar abscess.

Screening

There are no screening recommendations for peritonsillar abscess.

References

Template:WH Template:WS

Risk Factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2]

Overview

Common risk factors in the development of peritonsillar abscess include smoking, previous peritonsillar abscess episodes, history of recurrent Inflammation of the pharynx and tonsils.[1][2]

Risk Factors

Common risk factors in the development of peritonsillar abscess include:[1][2]

References

  1. 1.0 1.1 Lehnerdt G, Senska K, Fischer M, Jahnke K (2005). “[Smoking promotes the formation of peritonsillar abscesses]”. Laryngorhinootologie. 84 (9): 676–9. doi:10.1055/s-2005-870289. PMID 16142623.
  2. 2.0 2.1 Dilkes MG, Dilkes JE, Ghufoor K (1992). “Smoking and quinsy”. Lancet. 339 (8808): 1552. PMID 1351238.

Template:WH Template:WS

Natural History, Complications and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2]

Overview

Peritonsillar abscess if left untreated may result in extraperitonsillar extension.[1][2] Peritonsillar abscess may be complicated by airway obstruction, aspiration pneumonitis or lung abscess secondary to peritonsillar abscess rupture, hemorrhage from erosion or septic necrosis into carotid sheath, mediastinitis, poststreptococcal sequelae (e.g., glomerulonephritis, rheumatic fever) when infection is caused by Group A streptococcus, and necrotizing fasciitis[3][4][5][6][7] The prognosis of peritonsillar abscess is good with early and appropriate treatment.[8][9][10][11]

Natural history, complications and prognosis

Natural history

Peritonsillar abscess if left untreated may result in extraperitonsillar extension.[1][2]

Complications

The following are some complications that may follow peritonsillar abscess:[3][4][5][6][7]

  • Peritonsillar abscess may spread through the deep fascia of the neck with associated rapid progression to a more serious infection.

Prognosis

The prognosis of peritonsillar abscess is good with early and appropriate treatment.[8][9][10][11]

References

  1. 1.0 1.1 1.2 Coughlin AM, Baugh RF, Pine HS (2014). “Lingual tonsil abscess with parapharyngeal extension: a case report”. Ear Nose Throat J. 93 (9): E7–8. PMID 25255362.
  2. 2.0 2.1 2.2 Deeva YV (2015). “[SURGICAL TREATMENT OF TONSILLAR NECK PHLEGMON]”. Klin Khir (7): 47–8. PMID 26591220.
  3. 3.0 3.1 Galioto NJ (2008). “Peritonsillar abscess”. Am Fam Physician. 77 (2): 199–202. PMID 18246890.
  4. 4.0 4.1 Goldenberg D, Golz A, Joachims HZ (1997). “Retropharyngeal abscess: a clinical review”. J Laryngol Otol. 111 (6): 546–50. PMID 9231089.
  5. 5.0 5.1 Stevens HE (1990). “Vascular complication of neck space infection: case report and literature review”. J Otolaryngol. 19 (3): 206–10. PMID 2355414.
  6. 6.0 6.1 Greinwald JH, Wilson JF, Haggerty PG (1995). “Peritonsillar abscess: an unlikely cause of necrotizing fasciitis”. Ann Otol Rhinol Laryngol. 104 (2): 133–7. doi:10.1177/000348949510400209. PMID 7857015.
  7. 7.0 7.1 Wenig BL, Shikowitz MJ, Abramson AL (1984). “Necrotizing fasciitis as a lethal complication of peritonsillar abscess”. Laryngoscope. 94 (12 Pt 1): 1576–9. PMID 6594557.
  8. 8.0 8.1 Powell J, Wilson JA (2012). “An evidence-based review of peritonsillar abscess”. Clin Otolaryngol. 37 (2): 136–45. doi:10.1111/j.1749-4486.2012.02452.x. PMID 22321140.
  9. 9.0 9.1 Apostolopoulos NJ, Nikolopoulos TP, Bairamis TN (1995). “Peritonsillar abscess in children. Is incision and drainage an effective management?”. Int J Pediatr Otorhinolaryngol. 31 (2–3): 129–35. PMID 7782170.
  10. 10.0 10.1 Johnson RF, Stewart MG, Wright CC (2003). “An evidence-based review of the treatment of peritonsillar abscess”. Otolaryngol Head Neck Surg. 128 (3): 332–43. doi:10.1067/mhn.2003.93. PMID 12646835.
  11. 11.0 11.1 Herzon FS (1995). “Harris P. Mosher Award thesis. Peritonsillar abscess: incidence, current management practices, and a proposal for treatment guidelines”. Laryngoscope. 105 (8 Pt 3 Suppl 74): 1–17. PMID 7630308.
  12. Kawabata M, Umakoshi M, Makise T, Miyashita K, Harada M, Nagano H; et al. (2016). “Clinical classification of peritonsillar abscess based on CT and indications for immediate abscess tonsillectomy”. Auris Nasus Larynx. 43 (2): 182–6. doi:10.1016/j.anl.2015.09.014. PMID 26527518.

Template:WH Template:WS

Diagnosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | X Rays | Other Imaging Findings | Other Diagnostic Studies

Treatment

Treatment

Medical Therapy | Primary Prevention | Secondary Prevention

Case Studies

Case Studies

Case #1

Template:Respiratory pathology


Template:WH Template:WS

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH